Effects of lipopolysaccharide on neurokinin A content and release in the hypothalamic-pituitary axis

Regulatory Peptides

Volumn 111, Issue 1-3, 2003, Pages 91-95

  De Laurentiis, Andrea ^a   Candolfi, Marianela ^a   Pisera, Daniel ^a   Seilicovich, Adriana ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Hypothalamus; Interleukin 6; Prolactin; Tachykinins; TNF

Indexed keywords

INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NEUROKININ A; PROLACTIN; TUMOR NECROSIS FACTOR ALPHA;

ADENOHYPOPHYSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HORMONE RELEASE; HYPOPHYSIS; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IN VITRO STUDY; IN VIVO STUDY; INJECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN SECRETION; RADIOIMMUNOASSAY; RAT;

ANIMALS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHALAMUS; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; NEUROKININ A; PITUITARY GLAND, ANTERIOR; PITUITARY GLAND, POSTERIOR; PROLACTIN; RADIOIMMUNOASSAY; RATS; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS);

EID: 0037471370     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(02)00258-6     Document Type: Article

References (34)

1. Maggi C.A. The mammalian tachykinin receptors. Gen. Pharmacol. 6:1995;911-944.
2. Maggio J. Tachykinins. Annu. Rev. Neurosci. 11:1988;13-28.
3. Nussdorfer G.G., Malendowicz L.K. Role of tachykinins in the regulation of the hypothalamo-pituitary-adrenal axis. Peptides. 19:1998;949-968.
4. Debeljuk L., Lasaga M. Modulation of the hypothalamo-pituitary-gonadal axis and the pineal gland by neurokinin A, neuropeptide K and neuropeptide γ Peptides. 20:1999;285-299.
5. Debeljuk L., Lasaga M., Horvath J., Duvilanski B.H., Seilicovich A., Díaz M.C. Effect of an anti-substance P serum on prolactin and gonadotropins in hyperprolactinemic rats. Regul. Pept. 19:1987;91-98.
6. Pisera D., Debeljuk L., Seilicovich A., Afione S., Duvilanski B., Díaz M.C.et al. Possible role of neurokinin A in the control of prolactin secretion in rats and hamsters. J. Neuroendocrinol. 3:1991;279-283.
7. Maggi C.A. The effects of tachykinins on inflammatory and immune cells. Regul. Pept. 70:1997;75-79.
8. Campos M.M., Calixto J.B. Neurokinin mediation of edema and inflammation. Neuropeptides. 34:2000;314-322.
9. Payne C.M., Heggie C.J., Brownstein D.G., Stewart J.P., Quinn J.P. Role of tachykinins in the host response to murine gammaherpesvirus infection. J. Virol. 75:2001;10467-10471.
10. Sterner-Kock A., Braun R.K., Van der Vliet A., Schrenzel M.D., McDonald R.J., Kabbur M.B.et al. Substance P primes the formation of hydrogen peroxide and nitric oxide in human neutrophils. J. Leukoc. Biol. 65:1999;834-840.
11. Lieb K., Fiebich B.L., Berger M., Bauer J., Schulze-Osthoff K. The neuropeptide substance P activates transcription factor NF-kappaB and kappa B-dependent gene expression in human astrocytoma cells. J. Immunol. 159:1997;4952-4958.
12. Fiebich B., Schleicher S., Butcher R., Craig A., Lieb A. The neuropeptide substance P activates p38 mitogen-activated protein kinase resulting in IL-6 expression independently from NF-κB. J. Immunol. 165:2000;5606-5611.
13. Dickerson C., Undem B., Bullock B., Winchurch R.A. Neuropeptide regulation of proinflammatory cytokine responses. J. Leukoc. Biol. 63:1998;602-605.
14. Roth J., de Souza G. Fever induction pathways: evidence from responses to systemic or local cytokine formation. Braz. J. Med. Biol. Res. 34:2001;301-314.
15. Turnbull A., Rivier C. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol. Rev. 79:1999;1-71.
16. Besedovsky H., Del Rey A. Immune-neuroendocrine interactions: facts and hypotheses. Endocr. Rev. 17:1996;64-102.
17. Mandrup-Poulsen T., Nerup J., Reimers J., Pociot F., Andersen H., Karlsen A.et al. Cytokines and the endocrine system. The immunoendocrine network. Eur. J. Endocrinol. 133:1995;660-671.
18. Rettori V., Les Dees W., Hiney J., Lyson K., McCann S. An interleukin-1-alpha-like neuronal system in the preoptic hypothalamic region and its induction by bacterial lipopolysaccharide in concentrations which alter pituitary hormone release. Neuroimmunomodulation. 1:1994;251-258.
19. Rivier C. Mechanisms of altered prolactin secretion due to the administration of interleukin-1 β into the brain ventricles of the rat. Neuroendocrinology. 62:1995;198-206.
20. De Laurentiis A., Pisera D., Duvilanski B., Rettori V., Lasaga A., Seilicovich A. Neurokinin A inhibits oxytocin and GABA release from the posterior pituitary by stimulating nitric oxide synthase. Brain Res. Bull. 53:2000;325-330.
21. Turrin N.P., Gayle D., Ilyin S.E., Flynn M., Langhans W., Schwatz G.J.et al. Pro-inflammatory and anti-inflammatory cytokine mRNA induction in the periphery and brain following intraperitoneal administration of bacterial lipopolysaccharide. Brain Res. Bull. 4:2001;443-453.
22. Whiteside M.B., Quan N., Herkenharn M. Induction of pituitary cytokine transcripts by peripheral lipopolysaccharide. J. Neuroendocrinol. 11:1999;115-120.
23. Kalra P., Dube M., Kalra S. The effects of interleukin 1 beta on the hypothalamic tachykinin, neurokinin A. Brain Res. 662:1994;178-184.
24. Ray D., Melmed S. Pituitary cytokine and growth factor expression and action. Endocr. Rev. 18:1997;206-228.
25. Marquetee C., Van Dam A., Can E., Laniece P., Crumeyrolle-Arias M., Fillion G.et al. Rat interleukin-1 binding sites in rat hypothalamus and pituitary gland. Neuroendocrinology. 62:1995;362-369.
26. Eriksson C., Nobel S., Winblad B., Schultzberg M. Expression of interleukin 1 alpha and beta, and interleukin 1 receptor antagonist mRNA in the rat central nervous system after peripheral administration of lipopolysaccharides. Cytokine. 12:2000;423-431.
27. Spangelo B.L., deHoll P.D., Kalabay L., Bond B.R., Arnaud P. Neurointermediate pituitary lobe cells synthesize and release interleukin-6 in vitro: effects of lipopolysaccharide and interleukin-1 beta. Endocrinology. 135:1994;556-563.
28. Yasin S.A., Costa A., Forsling M.L., Grossman A. Interleukin-1 beta and interleukin-6 stimulate neurohypophyseal hormone release in vitro. J. Neuroendocrinol. 6:1994;179-184.
29. Freeman M., Kanyicska B., Lerant A., Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol. Rev. 80:2000;1523-1631.
30. Magoul R., Dubourg P., Benjelloun W., Tramu G. Synaptic inputs of tachykinin-containing nerve terminals to target tyrosine-hydroxylase-, beta-endorphin- and neuropeptide Y-producing neurons of the arcuate nucleus. Double pre-embedding immunocytochemical study in the rat. J. Chem. Neuroanat. 6:1993;419-429.
31. Isovich E., Diaz M., Lasaga M., Pisera D., Zambruno C., Theas M.et al. Involvement of hypothalamic substance P in the effect of prolactin on dopamine release. NeuroReport. 5:1994;1752-1754.
32. De Laurentiis A., Pisera D., Caruso C., Candolfi M., Mohn C., Rettori V.et al. Lipopolysaccharide- and Tumor Necrosis Factor-α-induced changes in prolactin secretion and dopaminergic activity in the hypothalamic-pituitary axis. Neuroimmunomodulation. 10:2002;30-39.
33. Jessop D., Renshaw D., Larsen P., Chowdrey H., Harbuz M. Substance P is involved in terminating the hypothalamo-pituitary-adrenal axis response to acute stress through centrally located neurokinin-1 receptors. Stress. 3:2000;209-220.
34. Kalra P., Edwards T., Xu B., Jain M., Kalra S. The anti-gonadotropic effects of cytokines: the role of neuropeptides. Domest. Anim. Endocrinol. 15:1998;321-332.